Tyler Lewy

Tyler Lewy

Tyler Lewy

Neurovirologist at NIAID's Rocky Mountain Laboratories

I'm interested in how the brain coordinates its response to lethal human pathogens, and in what frontier models can and can't do with that kind of knowledge.

Doctorate
Ph.D.Virology, Rockefeller University
Experience
12 yrVirology, including BSL-3 containment
Publications
09Five as first author
Citations
446Google Scholar (opens in a new tab), Aug 2026
01About

Bench science, and the language to explain it.

I work on how the brain orchestrates protection against lethal human viruses. In practice that has meant West Nile, Powassan, yellow fever and SARS-CoV-2, all of it under BSL-3 containment. My dissertation at Rockefeller began with a question nobody in the lab was working on, and ended as a first-author paper in Immunity describing a signaling network that puts the brain into a defensive state before an infection ever arrives.

Working under containment requires balance. Protocols must be safe enough to prevent accidents or misuse, yet not so restrictive they hinder productive research. That same framework is critical to frontier AI. When a model answers a question about a pathogen, it raises two questions. One, does the answer contain real uplift or a plausible-sounding dead end. Two does the uplift present new dangers in the hands of a bad actor. My high-containment virology background makes me uniquely suited in the artificial intelligence space to help make that call.

But over a decade of biomedical research has taught me that the greatest findings at the bench mean nothing if you cannot communicate them to the world. Scientific writing is an underappreciated skill. It's one thing to write a paper your peers will understand. It's far more difficult to write a piece your mother-in-law can also digest. I lectured for the Biomedical Research After-School Scholars program at Rocky Mountain Laboratories, breaking down complex virology and epidemiology concepts into lab modules for middle school students, and I've advised multiple trainees, several with no prior biology experience, through graduate rotations, summer projects, and post-baccalaureate work. The writing below is the same skill turned on my own papers.

I came to these questions from the bench, not from machine learning. Deciding whether a model's biological output is dangerous takes someone who has worked with both models, biological and computational.

02Publications

Writing for the field

Research articles

  1. 01
    Brain endothelial cells orchestrate a neuroprotective antiviral state in the central nervous system in response to peripheral viral pattern sensing (opens in a new tab) Lewy T, Sierra MA, Pourshadi N, Hoffmann HH, Dinnon KH, Gola A, Wang W, Chen HA, Quirk C, Zhang H, Doyle MP, Mason CE, Diehl GE, Hohl TM, Fuchs E, MacDonald MR, Wu Z, Crowe JE, Rice CM, Lercher A.
    Immunity 2026
    59(7):1825–1842
    doi (opens in a new tab)
  2. 02
    An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma (opens in a new tab) Batista MN, Bordignon J, Pamplona Mosimann AL, Bobrowski T, Chen HA, Tobin-Xet G, Barrall EA, Prokhnevska N, Vaidya AB, Lewy T, Dinnon KH, Seifert LL, Zeck B, Quirk C, Ho YJ, Filliol A, Wolfisberg R, Jiang C, Cogliati B, Chiriboga L, Theise N, MacDonald MR, Kamphorst AO, Scheel TK, Sheahan TP, Billerbeck E, Lowe SW, Rosenberg BR, Rice CM.
    J Hepatology 2026
    doi (opens in a new tab)
  3. 03
    Antiviral innate immune memory in alveolar macrophages following SARS-CoV-2 infection ameliorates secondary influenza A virus disease (opens in a new tab) Lercher A, Cheong JG, Bale MJ, Jiang C, Hoffmann HH, Ashbrook AW, Lewy T, Yin YS, Quirk C, DeGrace EJ, Chiriboga L, Rosenberg BR, Josefowicz SZ, Rice CM.
    Immunity 2024
    57(11):2530–2546
    doi (opens in a new tab)
  4. 04
    A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resist (opens in a new tab) Le Pen J, Paniccia G, Bauer M, Hoffmann HH, Kinast V, Moncada-Velez M, Pinharanda A, Ricardo-Lax I, Stenzel AF, Rosado-Olivieri EA, Ashbrook AW, Dinnon KH, Doyle WC, Freije CA, Hong SH, Lee D, Lewy T, Luna JM, Peace A, Schmidt C, Schneider WM, Winkler R, Larson C, McGinn T, Menezes MR, Ramos-Espiritu L, Banerjee P, Poirier JT, Sánchez-Rivera FJ, Zhang Q, Casanova JL, Carroll TS, Glickman FJ, Michailidis E, Razooky B, MacDonald MR, Rice CM.
    PLoS Biology 2024
    22(9)
    doi (opens in a new tab)
  5. 05
    Viruses 2020
    12(3):328
    doi (opens in a new tab)
  6. 06
    AIDS Res Hum Retroviruses 2019
    35(3):276–286
    doi (opens in a new tab)

Reviews

  1. 07
    Spatial omics technologies at multimodal and single cell/subcellular level (opens in a new tab) Park J, Kim J, Lewy T, Rice CM, Elemento O, Rendeiro AF, Mason CE.
    Genome Biology 2022
    23(1):256
    doi (opens in a new tab)
  2. 08
    Yale J Biol Med 2017
    90(2):291–300
    PMID (opens in a new tab)

General audience

  1. 09
    Prized Writing 2014
    UC Davis · 25:113–119

Citation metrics and the full publication record are maintained on Google Scholar (opens in a new tab).

03Writing

Writing for everyone

Two examples. The first puts the published abstract of my own Immunity paper next to a plain-language version of the same finding, so you can see the input and the output at once. The second is a risk assessment: a Science paper on AI-designed bacteriophages, read against what building something dangerous would actually take.

04Contact

Get in touch

I'm always glad to talk about viruses, neuroimmunity, biosecurity, or how AI systems handle biological knowledge.

Email  ·  Google Scholar (opens in a new tab)  ·  Curriculum vitae (PDF)